Neogen Chemicals Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹220.02 crore, reflecting a quarter-on-quarter *(QoQ) increase of 5.44 per cent from ₹208.66 crore. This corresponds to a year-on-year *(YoY) growth of 9.23 per cent.
Operating Profit
Operating Profit stands at ₹31.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 6.48 per cent from ₹29.96 crore. This corresponds to a year-on-year *(YoY) decline of 7.91 per cent.
PBDT
PBDT stands at ₹12.59 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.04 per cent from ₹12.46 crore. This corresponds to a year-on-year *(YoY) decline of 43.67 per cent.
Profit Before Tax
Profit Before Tax stands at ₹5.76 crore, reflecting a quarter-on-quarter *(QoQ) increase of 11.84 per cent from ₹5.15 crore. This corresponds to a year-on-year *(YoY) decline of 62.23 per cent.
Net Profit
Net Profit stands at ₹3.69 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.50 per cent from ₹3.37 crore. This represents a 63.14 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Neogen Chemicals Ltd News
Neogen Chemicals Ltd Earnings
- YOY
- QOQ
Neogen Chemicals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Neogen Chemicals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Neogen Chemicals Ltd Financial Reports
Neogen Chemicals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Neogen Chemicals | 3.89% | 1.21% | 11.54% | 37.85% | 75.52% | 12.08% |
| Archean Chemical | 0.58% | 1.64% | -14.03% | 1.37% | 5.56% | -14.98% |
| Balaji Amines | 15.93% | 13.40% | 38.74% | 91.38% | 77.93% | 35.76% |
| Galaxy Surfact. | -1.13% | -1.75% | -5.88% | -9.58% | -12.87% | -25.72% |
| Fineotex Chem | 3.40% | 5.85% | 83.64% | 91.28% | 76.52% | 70.96% |
| Epigral | -0.73% | -2.40% | -14.51% | 32.55% | -23.06% | -35.98% |
| Gujarat Alkalies | -1.95% | -2.50% | -16.22% | 45.26% | 27.71% | 13.05% |
Company Info
Company Information
ED / MD / Promoter : Harin Haridas Kanani
Chairman & Non Executive Director : Anurag Surana
E D & Wholetime Director : Shyamsundar Radheshyam Upadhyay
Independent Non Exe. Director : Ranjan Kumar Malik
Independent Non Exe. Director : Avi Kersi Sabavala
Independent Non Exe. Director : Rajeshkumar Babulal Shah
Independent Non Exe. Director : Manoj Pati
Company Sec. & Compli. Officer : Unnati Kanani
Executive Director : Triplicane Commandoor Narasimhan Saikrishnan